Navigation Links
Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
Date:5/22/2012

MAPLE GROVE, Minn., May 22, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. announced today that Senior National Account Manager, Dave Zitnak received the prestigious McKesson Branded Pharmaceutical Representative of the Year Award at the annual McKesson National Sales Conference in Las Vegas, NV on May 8, 2012.  The award was presented by Greg Yonko, Senior Vice President of Purchasing at McKesson. 

(Photo: http://photos.prnewswire.com/prnh/20120522/NY11654)

San Francisco, CA-based McKesson, one of the largest pharmaceutical distributors in North America, distributing one-third of the medicines used every day, selected Zitnak as its Branded Pharmaceutical Representative of the Year for consistently demonstrating the attributes of collaboration, problem solving and ability to create win-win opportunities. 

Zitnak recently celebrated his 20th year with Upsher-Smith and has been calling on McKesson for six years.  He began his career as a sales representative, moving into positions of increasing responsibility including District Sales Manager and Manager of Sales Operations.

"We are honored that McKesson recognized Dave with its prestigious Branded Pharmaceutical Representative of the Year Award," said Tom Burke, COO, Upsher-Smith Laboratories.  "Dave's commitment to his customers has consistently earned him the reputation of being a highly trusted partner in the industry and reflects Upsher-Smith's unwavering commitment to our partnerships with all of our wholesaler customers."

About Upsher-Smith
Upsher-Smith Laboratories, Inc. is a privately held, U.S.-based company devoted to improving health and advancing wellness since 1919.  Upsher-Smith demonstrates its commitment to meeting the healthcare needs of its customers by developing, producing and marketing consumer and prescription products.  In addition to its strong heritage in generics, Upsher-Smith's branded businesses focus on women's health, dermatology and CNS therapeutic areas.  For additional information, visit http://www.upsher-smith.com.

About McKesson
McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit http://www.mckesson.com.


'/>"/>
SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
2. Upsher-Smith Presents Updated Extended-Release Topiramate Data (USL255) at AES Meeting
3. Upsher-Smith Laboratories Named Manufacturer of the Year by AmerisourceBergen Corporation
4. PK Study Comparing Upsher-Smiths Extended-Release Topiramate Formulation (USL255) With Topamax® Published Online In Epilepsia
5. Upsher-Smith Laboratories Begins Phase III Study of Intranasal Midazolam for Rescue Treatment of Seizure Clusters in Epilepsy Patients
6. Upsher-Smith Receives Prestigious DIANA Award for Third Year in a Row
7. Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall
8. Upsher-Smith Introduces Nexa™ Select With More Plant-Based DHA Than Any Other Once-Daily Single Gel Capsule Rx Prenatal Vitamin
9. Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
10. Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg
11. Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) to CNS Development Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 28, 2016  While Abbott,s announced purchase of ... valve repair and stent business, healthcare research firm ... more firmly into patient monitoring.  Kalorama said that ... device areas, with double-digit growth expected the next ... Advanced Remote Patient Monitoring . Abbott Laboratories ...
(Date:4/28/2016)... 2016  Marking its one year anniversary since ... cancer risk test, Color Genomics announced ... highly impact the most common hereditary cancers affecting ... Test analyzes hereditary cancer risks for breast, colorectal, ... The Color Test is physician ordered and includes ...
(Date:4/28/2016)... , April 28, 2016  The blood testing ... million dollars, according to Kalorama Information and The Freedonia ... immunoassays and nucleic acid testing.  The healthcare research firm ... progress in developing blood collection stations and in improving ... in Kalorama Information,s report, Blood Testing Market ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... 2016 , ... Diagnotes, a leader in digital healthcare communications, ... system in South Carolina, to provide its secure mobile communication platform. , “Healthcare ... drives workflow efficiencies and improves provider and patient satisfaction,” said Dr. Todd Rowland, ...
(Date:5/3/2016)... ... May 03, 2016 , ... Each year, about 800,000 people suffer from cerebral ... United States and account for one death every four minutes. Many people who ... HCR ManorCare is launching a video series called “Your Brain,” in conjunction with its ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... industry, announced today that Legacy Health is expanding its use of Intrigma’s cloud-based ... a highly successful initial proof of concept. The Portland, Oregon based health system ...
(Date:5/3/2016)... ... 03, 2016 , ... Huntington Beach orthopedic doctor , Dr. Rick Pospisil, ... be used to diagnose and treat joint problems. During this procedure, Dr. Pospisil makes ... special lighting system and lens that illuminate and magnify the various structures in the ...
(Date:5/3/2016)... ... May 03, 2016 , ... Finding the right way to address a patient’s condition before it ... now getting on board. , “You do the right thing, at the right time, at ... down, not up,” said Leonard M. Fromer, MD, FAAFP, from Group Practice Forum. “Even if ...
Breaking Medicine News(10 mins):